Journal of Pharmaceutical Sciences, 111(5), 1234-1245
Novos Multi-Front Momentum: 20262027 Beyond CagriSema, Novo Nordisk is firing on all cylinders to compete in this fierce 2-horse race (Figure 2): Wegovy 7.2 mg Approval: In February 2026, the European Commission approved a more effective 7.2 mg dose of injectable Wegovy
Based on the individuals response and tolerability, healthcare providers may increase this dosage at incremental levels up to a maximum of 15 milligrams per week
Antibiotics use is another strategy Numerous studies have shown that the use of antibiotics can significantly reduce circulating TMAO levels, possibly due to changes in the gut microbiota composition
It is a provider-led telehealth program where patients work with the same clinician, Bonnie Lea Davis, FNP-C, for personalized weight-management support